DrugPatentWatch Database Preview➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing
« Back to Dashboard
Lisofylline is an investigational drug.
There have been 4 clinical trials for Lisofylline. The most recent clinical trial was a Phase 3 trial, which was initiated on September 1st 1994.
The most common disease conditions in clinical trials are Diabetes Mellitus, Type 1, Diabetes Mellitus, and Lung Diseases. The leading clinical trial sponsors are National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), National Heart, Lung, and Blood Institute (NHLBI), and Eastern Virginia Medical School.
Recent Clinical Trials for Lisofylline
|Lisofylline as Continuous Subcutaneous and Intravenous Administration in Subjects With Type 1 Diabetes Mellitus||Eastern Virginia Medical School||Phase 1/Phase 2|
|Subcutaneous Administration of Lisofylline to Healthy Normal Subjects and Subjects With Type 1 Diabetes||DiaKine Therapeutics, Inc.||Phase 1/Phase 2|
|Strategies to Improve Islet Survival||National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)||Phase 2|